Press Release | Sep 06, 2017

Nutrition 21, LLC is pleased to announce its expanded partnership with American Media, Inc. (AMI) that is dedicated to educating consumers on the benefits of Nitrosigine. Nitrosigine is scientifically engineered to significantly boost nitric oxide levels, a key factor in increasing blood flow to working muscles^ and is formulated to help consumers train longer, harder

Press Release | Aug 23, 2017

Colorescience®, the leading dermatologist-recommended skin health cosmetics company, is proud to introduce the innovative All Calm™ Clinical Redness Corrector. Formulated for redness, rosacea and sensitive skin, this first-of-its-kind formula instantly calms and soothes skin while its subtle green undertones neutralize redness, and its patent-pending BioSolaceTM complex helps provide ongoing relief from sensitivity and the appearance

News | Aug 04, 2017

Adele is bringing the firm she co-founded, 1315 Capital, L.P., into the newest round for the cosmetics company that Mary spun off from SkinMedica. Colorescience raised $15-million in Series C financing in a round led by 1315.

Press Release | Aug 01, 2017

Colorescience®, the leading dermatologist-recommended skin health cosmetics company, today announced the successful completion of a $15 Million Series C Preferred Stock financing led by 1315 Capital, L.P., a Philadelphia-based healthcare investment firm that specializes in providing expansion and growth capital to specialty pharmaceutical, medical technology, and healthcare services companies.

Press Release | Jul 10, 2017

Nutrition 21’s patented ingredient combining amylopectin and chromium, brand named Velositol, has attained GRAS (generally recognized as safe) status after an extensive and rigorous review of the scientific dossier and safety data conducted by Intertek Health Sciences, Inc.

Press Release | Jun 28, 2017

Bionano Genomics and Genoptix today announced an exclusive agreement to codevelop diagnostic assays for selected hematologic oncology indications. Bionano will contribute its knowledge of genome structure analysis and its Saphyr system, which is designed to accurately visualize the structure of a genome with a simple DNA sample, isolated directly from cancer cells. The platform can

News | Jun 20, 2017

Another noteworthy feature of emerging managers is that many of them have created new or different models for their firms and for making VC investments. “We leverage a unique, team-based operating partner model of CEO and longtime executive partners who collaborate with us,” said Adele Oliva, Founding Partner of Philadelphia-based healthcare expansion and growth equity

Press Release | Jun 07, 2017

1315 Capital, LLC, an expansion and growth equity firm that invests in commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, announced today the continued expansion of its senior investment team with the addition of Matthew Q. Reber as a Partner. Mr. Reber joins Founding Partners, Adele C. Oliva and Michael Koby, and brings deep

Pages 1 2 3 4 5 6